“drug-prices” Archives

in
Entry Author Date Location
BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation 09/17/20 Boston
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy 08/07/20 National
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
White House Floats Canadian Import Plan But Excludes Many Costly Drugs 07/31/19 National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Bluebird Bio Sets $1.8M Price on Gene Therapy for Rare Blood Disease 06/14/19 Boston
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson 04/23/19 Boston
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More 04/12/19 National
Senators Grill Pharmacy Benefit Execs About Skyrocketing Drug Prices 04/09/19 National
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Drug-Price Watchdog ICER Dives into Trump-Fueled Pharma Rebate Debate 03/13/19 National
Two Years and Done: FDA Commissioner Gottlieb To Resign 03/05/19 National
Lilly to Launch “Authorized Generic” Insulin Priced at 50% Discount 03/04/19 Indiana
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away 02/26/19 National
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More 01/11/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Amgen Slashes Cholesterol Drug Price 60% to Match Rival Regeneron 10/24/18 National
Report: Express Scripts Shuts Out Teva Migraine Drug, Prefers Rivals 10/17/18 National
Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More 08/31/18 National
Bio Roundup: Alnylam’s Moment, Read on Rebates, Skinny Plans & More 08/03/18 National
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Page 1 of 2 next page »